Profile
LUCY ISRG BDX BDXA ALC RMD
Company Name Innovative Eyewear, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $10.26M $184.84B $65.60B $64.58B $45.56B $34.14B
Employees 0.01K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Mr. Harrison Reed Gross Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. - Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM
Ratings
LUCY ISRG BDX BDXA ALC RMD
Quant Rating Score 1 3 3 5 3 4
Quant Rating Strong Sell Neutral Neutral Strong Buy Neutral Buy
Trading
LUCY ISRG BDX BDXA ALC RMD
Last Close $3.71 $482.61 $227.45 $59.24 $89.94 $236.63
High 52 $10.79 $610.45 $249.08 $59.24 $100.76 $257.65
Low 52 $0.19 $366.34 $220.02 $59.24 $77.58 $173.83
Price vs. 52 Week High -65.62 % -20.94 % -8.68 % 0 % -10.74 % -8.16 %
Price vs. 52 Week Low 1852.63 % 31.74 % 3.38 % 0 % 15.93 % 36.13 %
Total Return
LUCY ISRG BDX BDXA ALC RMD
1 Month Return -24.29 % -18.43 % -0.9 % 0 % 0.14 % -0.34 %
3 Month Return -39.97 % -11.22 % 2.9 % 0 % 3.89 % -3.72 %
6 Month Return -31.55 % -1.69 % -2.67 % 0 % -8.43 % -6.44 %
9 Month Return 635.67 % 15.24 % -3.19 % 0 % -0.76 % 12.58 %
YTD Return -24.59 % -7.54 % 0.26 % 0 % 5.95 % 3.47 %
1 Year Return 899.73 % 27.37 % -5.03 % 0 % 2.03 % 24.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LUCY ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.7 % 1.73 % 0.29 % 0.89 %
Dividend Paid and Capex Coverage Ration (TTM) -160284.95 % 1.96 % 1.98 % 1.98 % 2.05 % 3.84 %
Dividend Per Share (TTM) - - 3.89 % 3.89 % 0.26 % 2.07 %
Payout Ratio (TTM) - 0.34 % 65.26 % 65.26 % 13.01 % 23.76 %
Profitability
LUCY ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM -3.76 % 67.46 % 45.22 % 45.22 % 55.61 % 57.94 %
Return on Assets TTM -14891.91 % 12.39 % 3.16 % 3.16 % 3.35 % 17.49 %
Return on Equity TTM -24906.65 % 15.31 % 6.73 % 6.73 % 6.43 % 25.05 %
Return on Capital Employed TTM -44.91 % 13.82 % 5.64 % 5.64 % 5.03 % 24.81 %
Net Income Per EBT TTM 21495.76 % 86.87 % 88.43 % 88.43 % 81.05 % 81.35 %
EBT Per Ebit TTM 163.47 % 113.83 % 73.61 % 73.61 % 88.89 % 98.37 %
EBIT Per Revenue TTM -314.73 % 28.12 % 12.85 % 12.85 % 14.24 % 31.67 %
Cash Flow To Debt Ratio TTM - - 19.46 % 19.46 % 36.06 % 175.81 %
Receivables Turnover TTM 13.62 6.16 7.82 7.82 4.77 5.73
Payables Turnover TTM 2.66 14.05 - - 5.7 9.41
Inventory Turnover TTM 1.77 1.83 2.93 2.93 1.94 2.35
Fixed Asset Turnover TTM 1463.61 % 179.75 % 312.63 % 312.63 % 205.17 % 734.05 %
Asset Turnover TTM 13.46 % 44.56 % 37.76 % 37.76 % 32.71 % 68.99 %
Operating Cash Flow Per Share TTM -2762.71 6.14 12.61 12.61 3.75 10.05
Free Cash Flow Per Share TTM -2762.73 3.02 10.14 10.14 2.19 9.45
Cash Per Share TTM 261620.11 % 1126.07 % 251.46 % 251.46 % 370.15 % 355.4 %
Operating Cash Flow Sales Ratio TTM -307286.06 % 26.2 % 17.68 % 17.68 % 18.66 % 29.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 49.22 % 80.44 % 80.44 % 58.38 % 94.04 %
Cash Flow Coverage Ratios TTM - - 19.46 % 19.46 % 36.06 % 175.81 %
Price To Free Cash Flows Ratio TTM - 171.59 22.34 22.04 42.14 24.59
Price To Operating Cash Flows Ratio TTM - 84.4 18.12 17.87 24.59 23.12
Price Cash Flow Ratio TTM - 84.4 18.12 17.87 24.59 23.12
Income Statement (TTM)
LUCY ISRG BDX BDXA ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $-0B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio -10.4% 67.5% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.01B $2.67B $4.85B $4.85B $2.68B $1.53B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -12.67 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
LUCY ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.01B $16.53B $25.91B $25.91B $21.55B $4.86B
Total Investments $0B $6.81B $0.45B $0.45B $0.75B $0.17B
Total Debt $0B $0B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
LUCY ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.84B $3.84B $2.08B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.635
ALC Alcon Inc. 89.19
ANGO AngioDynamics, Inc. 9.11
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.9
ATRC AtriCure, Inc. 33.94
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 40.62
BAX Baxter International Inc. 35.845
BDX Becton, Dickinson and Company 224.925
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.597
BLFS BioLife Solutions, Inc. 26.64
COO The Cooper Companies, Inc. 80.96
DXR Daxor Corporation 7.7871
EKSO Ekso Bionics Holdings, Inc. 0.3797
FEMY Femasys Inc. 1.5049
ETFs With Exposure to LUCY
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 172.82
DFAT Dimensional U.S. Targeted Value ETF 0.00000185 51.32
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 130.87
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 130.88
VEMPX Vanguard Extended Market Index InstlPlus 0 322.98
Unlock